HighMark Wealth Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

HighMark Wealth Management’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-530	Closed	-$10K	–	490
2020 Q2	$10K	Sell	530 -10,000	-95%	-$139K	0.01%	206
2020 Q1	$75K	Sell	10,530 -4,258	-29%	-$53.1K	0.09%	55
2019 Q4	$353K	Buy	+14,788	New	+$408K	0.38%	21

HighMark Wealth Management's PTLA Position: Q3 2020 in Review

HighMark Wealth Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 530 shares — an estimated $10K sold.

HighMark Wealth Management first reported a position in PTLA in Q4 2019 and held it in 3 quarters. The position peaked at $353K in Q4 2019. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

HighMark Wealth Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
HighMark Wealth Management sold 530 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $10K.
HighMark Wealth Management first reported a position in Portola Pharmaceuticals, Inc. in Q4 2019 and held it in 3 quarters.
HighMark Wealth Management's Portola Pharmaceuticals, Inc. position peaked at $353K in Q4 2019.
0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on HighMark Wealth Management's 13F filing for Q3 2020, filed 26 Oct 2020.